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Abstract
Background: The commitment to promoting equity in health is derived from the notion that all human beings
have the right to the best attainable health. However, disparities in health care are well-documented. The
objectives were to explore disparities in diabetes prevalence, care and control among diabetic patients. The study
was conducted by Maccabi Healthcare Services (MHS), an Israeli HMO (health care plan).
Methods: Retrospective study. The dependent variables were diabetes prevalence, uptake of follow-up
examinations, and disease control. The independent variables were socio-economic rank (SER), ethnicity (Arab vs
non Arab), supplementary voluntary health insurance (SVHI), and immigration from Former Soviet Union (FSU)
countries. Chi Square and Logistic Regression Models were estimated.
Results: We analyzed 74,953 diabetes patients. Diabetes was more prevalent in males, lower SER patients, Arabs,
immigrants and owners of SVHI. Optimal follow up was more frequent among females, lower SERs patients, non
Arabs, immigrants and SVHI owners. Patients who were female, had higher SERs, non Arabs, immigrants and SVHI
owners achieved better control of the disease. The multivariate analysis revealed significant associations between
optimal follow up and age, gender (males), SER (Ranks 1-10), Arabs and SVHI (OR 1.02, 0.95, 1.15, 0.85 and 1.31,
respectively); poor diabetes control (HbA1C > 9 gr%) was significantly associated with age, gender (males), Arabs,
immigrants, SER (Ranks1-10) and SVHI (OR 0.96, 1.26, 1.38, 0.72, 1.37 and 0.57, respectively); significant associations
with LDL control (< 100 gr%) were revealed for age, gender (males) and SVHI (OR 1.02, 1.30 and 1.44, respectively).
Conclusion: Disparities in diabetes prevalence, care and control were revealed according to population sub-group.
MHS has recently established a comprehensive strategy and action plan, aimed to reduce disparities among
members of low socioeconomic rank and Arab ethnicity, sub-groups identified in our study as being at risk for less
favorable health outcomes.
Background
The commitment to promoting equity in health care is
derived from the notion that all human beings have the
right to the best attainable health [1]. Adoption of
health as a basic human right by the United Nations [2]
and by the WHO in 1978 [3] established health equity
as a moral commitment for governments and health
organizations.
Inequity in health is defined as “the presence of sys-
tematic and potentially remediable differences in one or
more aspects of health across socially, demographically,
or geographically defined populations or population
sub-groups” [4]. These differences are not only unneces-
sary and avoidable, they are considered unfair and
unjust [5].
In 2001, the American Institute of Medicine (IOM)
suggested six dimensions to define quality of care. One
of them is care’s equity, meaning that the quality of
care is not influenced by personal characteristics such
as gender, ethnicity, geography, and social or economic
status [6]. However, disparities in health care have
been well-documented over the years [7-11].
Israel has a universal health care insurance system
that is financed through taxation linked to income and
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plans, referred to in Hebrew as “sick funds”. Each non-
profit plan is required to provide its members with a
basic benefits package that includes physician services,
hospitalization and outpatient care. Enrollment in one
of the health plans is by free choice; plan denial of
enrollment is prohibited.
In addition, all Israeli health plans offer their members
the opportunity to purchase supplementary voluntary
health insurance (SVHI) that enlarges the package [12].
Despite the universal coverage by a broad package of ser-
vices, disparities in provision of health services and in
health outcomes exist and broadened during the last two
decades [13-18].
Diabetes is one of the most common chronic diseases
that places a sizeable burden on patients, health care sys-
tems, and society [19]. As in other countries, diabetes pre-
valence in Israel has risen over the last few decades,
reaching a prevalence of 6.4% in adults (aged 18+), an
annual increase of 0.2% [13].
Maccabi Healthcare Services (MHS) is an Israeli health
plan providing community-based health services
throughout the country to 1.8 million members from
diverse population groups. Services are provided in five
regional and 150 local branches (the basic administrative
unit), based on a core staff of some 3,000 independent
physicians. These physicians are self-employed, working
from either MHS clinics located in the branches or their
private offices. Most have solo practices. In 2004, MHS
implemented an organizational “Performance Measure-
ment System” (PMS) that measures performance accord-
ing to a set of 24 indicators in six clinical domains,
including diabetes. The PMS derives its data from the
operational database housed in the organization’sm a i n
computer. Measures are analyzed and reported on a
monthly basis at the regional and branch levels; they are
then distributed to all managers and caregivers. These
steps cast light on disparities and raised the awareness of
equity issues within the organizational discourse. As a
result, MHS management has decided to adopt improve-
ment of equity as a strategic goal. One consequence of
that decision was to shift analysis of performance data
from the organizational unit level (region or branch) to
the individual member level in order to better understand
the relationship between member characteristics and
health outcomes.
This article presents the results of an analysis of the
associations between socio-economic status, ethnicity,
ownership of supplementary voluntary health insurance
(SVHI), immigration, and diabetes prevalence and care
measures. In the discussion we describe the strategy
and action plan that MHS has taken in wake of the
results.
Methods
Setting
MHS, the second largest health plan in Israel, with
1,807,521 members when the study was performed.
Study Period
Data were extracted on November 15, 2008 (Due Day)
and reflects care provided during the previous 12 months
(December 2007-November 2008)
Study Subjects
Our reference population for the assessment of diabetes
prevalence among different groups consisted of all MHS
members, aged 18-80, who had visited a general practi-
tioner (GP) at least once during the previous two years.
The study population (diabetic patients) for the assess-
ment of diabetes care and control were all MHS mem-
bers, aged 18-80, who were recorded in the computerized
Diabetes Registry (DR) on the due day and visited a GP
at least once during the previous two years. We used the
latter criterion as a proxy for a routine patient-physician
relationship in all measures that reflect care at the prac-
tice level.
Diabetes Registry (DR)
Diabetic patients were defined according to the criteria
suggested by the American Diabetes Association [20].
Symptoms were diagnosed as diabetes with fasting
plasma glucose > 125 mg/dL or casual (namely, any
time of day without regard to time since last meal)
plasma glucose concentration ≥200 mg/dL, in addition
to a diabetes diagnosis documented in the medical
records. Patients were included also if they (1) pur-
chased at least two hypoglycemia medications or a sin-
gle insulin dose during any six-month period or (2) had
HbA1C results of at least 7.25 gr%. HbA1C of 6.5 gr%
was used as an entry criterion only if a diabetes diagno-
sis had been documented in the electronic medical
records [21]. Women of child-bearing age who entered
t h eD Rd u et oo n ep u r c h a s eo fi n s u l i nb u tw i t h o u ta n y
other diabetic medications or no purchase of insulin for
the next three months were considered Gestational Dia-
betics and subsequently excluded.
Data sources
Data were extracted from: (1) the MHS computerized
DR and billing system, (2) the MHS computerized PMS,
(3) Israel’s Census Registry for data on Socio-Economic
Rank (SER) and ethnicity.
Performance measures
In order to assess the effectiveness of management of
diabetes care and its potential complications, we
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sures: HbA1C and LDL cholesterol testing, a pre-defined
optimal follow-up, and intermediate outcome measures:
HbA1C control and LDL cholesterol control.
Definitions
HbA1C testing
Proportion of patients registered in the DR who per-
formed at least one HbA1C test during the previous
year.
LDL cholesterol test
Proportion of patients registered in the DR who per-
formed at least one LDL cholesterol test during the pre-
vious year.
Optimal Follow-up
This is an “all or none measure” [22], which includes
performance of all the following tests: HbA1C testing,
LDL Cholesterol testing, nephropathy monitoring (urine
micro-albumin), eye and foot exams, blood pressure and
Body Mass Index recording.
Intermediate outcomes
(1) Poor HbA1C control: Proportion of DR patients who
performed an HbA1C test during the previous year and
had demonstrated HbA1C ≥9g r % ;( 2 )Appropriate LDL
control: Proportion of DR patients who performed an
LDL test in the previous year and had achieved LDL
cholesterol ≤ 100 mg%.
Socio Economic Rank (SER)
Israel is divided into geographic sub-districts, each with a
population of approximately 3,000. Israel’sC e n t r a l
Bureau of Statistics characterizes each sub-district
according to a socio-economic status ranking system
based on the 1995 national census, updated in 2003. Sub-
districts are ranked on a scale of 1-20, with 1 being the
lowest and 20 the highest. The following variables are
among those included in the SER equation: housing den-
sity, household employment, income, and education [23].
In our analysis, subjects were assigned to a sub-district
according to his or her last recorded address and then
ranked for socio-economic status by that sub-district.
Supplementary Voluntary Health Insurance (SVHI)
As mentioned, Israel has a universal health care system
with a unified benefits package of services provided by
four health plans. All health plans offer their members
the opportunity to purchase SVHI for services that are
not included in the basic package, such as certain types
of medical devices or greater choice among the services
included in the package. Every member, irrespective of
health status, can purchase his or her plan’sS V H I ;t h e
tariff is age-based and not related to health status. Rele-
vant benefits that diabetic patients can utilize include,
for example, reduced prices when purchasing devices for
self-monitoring of blood glucose levels, reimbursement
for consultations with private experts; and reduced co-
payment for sophisticated new drugs. 87% of DR MHS
members and 88% of all MHS members have SVHI.
Ethnicity (Arabs vs. Non Arabs)
Since personal data on ethnicity are not available to
HMOs, Israeli Arabs were identified by the ethnicity of
their residence in a settlement or (in large mixed cities
such as Nazareth) by their sub-district, as recorded in
the National Census. By using this method, we estimate
that 90% of MHS’s Arab members were allocated.
Immigration
Starting in 1990, Israel became the objective of a wave
of immigration (about 1 million people) from countries
belonging to the Former Soviet Union (FSU). These
immigrants contributed to 15% growth in total popula-
tion. The MHS data set contains immigration status for
this group of immigrants only. Thus, under the term
“Immigration,” we considered only these immigrants.
We should note that other immigration groups arriving
during this period are relatively small in number.
Data set construction
We combined the MHS DR, Billing System, PMS, and
Israeli Census into one data set using the AS400 query
system.
Statistical Methods
(A) We performed an analysis of variance for prevalence
as well as for process and intermediate outcome mea-
sures, between sub-groups (Gender, SERs, Ethnicity,
Immigration and SVHI) using Chi-square techniques;
(B) Logistic Regression Models were estimated for three
dependent variables: (1) Optimal follow-up; (2) recorded
HbA1C > 9 gr% and (3) achieving LDL < 100 gr.%. The
independent variables were included in the models
according to whether they reached the significance level
(p ≤ 0.05) in the univariant analysis. For SER, we
included SER 1-10 and 11-20 as two separate dummy
variables in the final models although we compared four
ranks in the univariant analysis. Our decision was based
on the fact that in the univariant analysis, the SER cate-
gories 1-5 and 6-10 differed from the two others (11-15
and 16-20), and the preliminary models indicated robust
results only for two rather than four dummies. Odds
Ratios (OR) and 95% Confidence Intervals (95%CI) were
calculated.
Results
MHS members aged 18-80 who had visited their GP at
least once during the previous two years numbered
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ble for participation in this study and thus served as our
study population. Included were 53.9% males and 46.1%
females; mean age was 58.8 (± 11.4) and 60.1 (± 12.2)
for males and females, respectively; 6% were ineligible
due to the fact that they have not visited their GP at
least once during the previous two years.
Diabetes Prevalence
Diabetes was more prevalent in males when compared
to females, members with a lower SER (1-10) when
compared to a higher SERs (11-20), Arabs as opposed
to non Arabs, immigrants from FSU countries when
compared with veteran residents, and SVHI owners
when compared to non owners. All differences were sta-
tistically significant (p < 0.001; see Table 1).
HbA1C Testing
Higher percentages of HbA1C testing were observed in
females when compared to males, members with a
lower SERs (1-10) when comparing to a higher SERs
(11-20), and immigrants from FSU countries when com-
pared to veteran residents, and SVHI owners when
compared to non owners. All differences were statisti-
cally significant (p < 0.001). Differences in performing
HbA1C between Arabs and non Arabs were not statisti-
cally significant (P = 0.276; see Table 1).
LDL Testing
Higher percentages of LDL testing were observed for
females when compared with males, non Arabs when
compared with Arabs, immigrants from FSU countries
when compared to veteran residents, and SVHI owners
when compared to non owners. All differences were sta-
tistically significant (p < 0.001) for Arabs as compared
with non Arabs (P = 0.049). Differences in performing
LDL testing by SER were not statistically significant (P =
0.152; see Table 1).
Optimal Follow Up
Higher percentages of optimal follow up were observed
for females when compared to males, lower SERs (1-5)
when comparing with other SER ranks, non Arabs when
compared to Arabs, and SVHI owners when compared
with non owners. All differences were statistically signif-
icant (p < 0.001; for Arabs when compared with non
Arabs, P = 0.049). Differences in performing LDL testing
between FSU immigrants and veteran residents were not
statistically significant (P = 0.580; see Table 1).
Intermediate Outcomes - Disease Control
Poor diabetes control
The percentage of patients achieving HbA1C levels
exceeding 9 gr% was higher for males when compared
with females, for patients belonging to the 1-5 and 6-10
SERs when compared with those belonging to the 11-15
and 16-20 SERs, for Arabs when compared with non
Arabs, for veterans when compared to immigrants from
FSU countries and for non owners when compared to
owners of SVHI. All differences were statistically signifi-
cant (p < 0.001; see Table 2).
Appropriate LDL control
The percentage of patients achieving LDL cholesterol
levels below 100 gr% were higher among males when
compared with females, among members in the 11-15
and 16-20 SERs when compared with those in the 1-5
Table 1 Prevalence (%) and process measures performed (%) by gender, SER, immigration, ethnicity and SVHI
Variable Prevalence P Value HbA1C Testing P Value LDL Testing P Value Optimal F/U P Value
Gender
Males 8.4 85.0 84.3 23.7
Females 6.2 <0.001 86.3 <0.001 85.2 <0.001 24.7 0.002
SER
1-5 9.0 86.2 84.2 26.5
6-10 8.8 86.2 84.9 24.5
11-15 7.7 85.7 85.2 23.5
16-20 6.2 <0.001 85.1 <0.001 84.7 <0.001 24.9 <0.001
Ethnicity
Arabs 8.2 86.3 83.5 21.2
Non Arabs 7.1 <0.001 85.6 0.276 84.8 0.049 24.4 <0.001
Immigration
Immigrants 10.1 87.5 86.7 24.3
Veterans 6.7 <0.001 85.0 <0.001 84.7 <0.001 24.1 0.580
SVHI
Owners 7.3 86.3 85.3 24.6
Non Owners 6.8 <0.001 80.8 <0.001 80.4 <0.001 20.3 <0.001
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Arabs, and among SVHI owners when compared with
non owners. All differences were statistically significant
(p < 0.001; see Table 2).
Multi-Variant Analysis
The regression models for optimal follow up revealed
positive and statistically significant associations with age
(OR = 1.02 95%, 95%CI = 1.019-1.022); SVHI (OR =
1.31, 95%CI = 1.239-1.400) and SER 1-10 (OR = 1.15,
95%CI = 1.107-1.198). Negative associations were
revealed with being Arab (OR = 0.85, 95%CI = 0.766-
0.950) and male (OR = 0.95, 95%CI = 0.924-0.995) (see
Table 3). For poor diabetes control, positive and statisti-
cally significant associations were found with being male
(OR = 1.26, 95%CI = 1.193-1.346), Arab (OR = 1.38,
95%CI = 1.219-1.581), and having an SER of 1-10 (OR =
1.37, 95%CI = 1.288-1.463). Negative but not significant
associations were found with age (OR = 0.96, 95%CI =
0.963-0.968), ownership of SVHI (OR = 0.57; 95%CI =
0.531-0.629) and being an immigrant from the FSU (OR
= 0.72, 95%CI = 0.669-0.784) (see Table 4). For achiev-
ing adequate LDL cholesterol control, positive and
significant associations were found with age (OR = 1.02,
95%CI = 1.026-1.029), being male (OR = 1.30, 95%CI =
1.260-1.351), and SVHI ownership (OR = 1.44, CI =
1.366-1.529) (see Table 5).
Discussion
This study was conducted to identify the associations
between socioeconomic and demographic characteristics
and quality of diabetes care in order to identify popula-
tions at risk for less favorable health outcomes. Our
findings indicated differences in diabetes prevalence and
effective disease management between population
groups as defined by their socioeconomic position and/
or ethnicity. These findings are of special importance in
light of the fact that Israel has a national health care
system providing a universal broad benefit package of
services.
SER
With respect to MHS members, we found a negative
association between socioeconomic status and diabetes
prevalence as well as intermediate outcome measures.
These differences are not new. In 2007 it was published
that diabetes prevalence in Israel was five times greater
for people with social security tax payment exemptions
(a proxy for low socioeconomic ranking) when com-
pared with the general population [13]. Diabetes preva-
lence was twice as high among Israelis having only eight
years of education when compared with those with at least
twelve years of education (12% and 5.8%, respectively).
Among Arabs, the gaps were even larger (11.5% and 3.7%
for 8 and 12+ years of education, respectively) [23]. In a
Table 2 Intermediate outcome measures achieved (%), by
gender, SER, immigration, ethnicity and SVHI
Variable HbA1C > 9 gr% P Value LDL < 100 P Value
Gender
Males 10.9 55.5
Females 8.5 <0.001 50.0
SER
1-5 13.9 51.6
6-10 10.9 51.8
11-15 8.5 53.3
16-20 7.3 <0.001 55.9
Ethnicity
Arabs 20.5 45.4
Non Arabs 9.1 <0.001 53.5
Immigration
Immigrants 7.2 53.4
Veterans 10.5 <0.001 52.9
SVHI
Owners 9.0 54.0
Non Owners 15.9 <0.001 45.0
Table 3 Results of the logistic regression analysis: final
model for dependent variable: optimal follow up
Variable B SE
1 P Value OR
2 95% CI
3
Age 0.020 0.001 <0.001 1.02 1.019-1.022
Gender -0.042 0.019 0.026 0.95 0.924-0.995
Ethnicity -0.159 0.055 0.004 0.85 0.766-0.950
SER1-10 0.141 0.020 <0.001 1.15 1.107-1.198
SVHI 0.276 0.031 <0.001 1.31 1.239-1.400
1Standard Error;
2 Odds Ratio;
395% Confidence Interval.
Table 4 Results of the logistic regression analysis: final
model for dependent variable: HbA1C > 9 gr%
Variable B SE
1 P Value OR
2 95% CI
3
Age -0.035 0.001 <0.001 0.96 0.963-0.968
Gender 0.237 0.031 <0.001 1.26 1.193-1.346
Ethnicity 0.328 0.066 <0.001 1.38 1.219-1.581
SER1-10 0.317 0.032 <0.001 1.37 1.288-1.463
SVHI -0.548 0.043 <0.001 0.57 0.531-0.629
Immigration -0.323 0.040 <0.001 0.72 0.669-0.784
1Standard Error;
2Odds Ratio;
395% Confidence Interval.
Table 5 Results of the logistic regression analysis: final
model for dependent variable: LDL < 100 gr%
Variable B SE
1 P Value OR
2 95% CI
3
Age 0.027 0.001 <0.001 1.02 1.026-1.029
Gender 0.266 0.018 <0.001 1.30 1.260-1.351
Ethnicity -0.094 0.050 0.061 0.91 0.826-1.005
SER1-10 -0.002 0.019 0.908 0.99 0.961-1.036
SVHI 0.368 0.29 <0.001 1.44 1.366-1.529
1Standard Error;
2Odds Ratio;
395% Confidence Interval .
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care Research and Quality, disparities in diabetes
management and complications among American popu-
lation sub-groups were demonstrated. White adults
with high incomes and some college or higher education
were more likely to receive recommended diabetic ser-
vices and less likely to be exhibit disease-related compli-
cations [24].
Outcomes of diabetes care are multifaceted, compris-
ing aspects of patient education regarding the taking of
personal responsibility and self-care, compliance with
customized treatment plans, maintenance of a strict
diet, adoption of a healthy life style, and automatic and
regular checking of blood glucose levels. These actions
are associated with personal socio-demographic charac-
teristics such as education, income, and mobility, as well
as psychological, social, and cultural resources.
Based on extensive recently compiled documentation,
it appears that communities in Israel’s peripheries suffer
from inadequate access to high quality of care [25]. The
inhabitants of those regions also tend to be from poor
s o c i o - e c o n o m i cb a c k g r o u n d s .W ea s s u m et h a td u et o
the inability of health organizations to mobilize good
caregivers willing to serve in these regions, the likeli-
hood that the residents will achieve poor health out-
comes is increasing.
Our findings also revealed that members from poor
socio-economic backgrounds performed relatively well
according to process measures but demonstrate wide
disparities regarding intermediate outcome measures
when compared with MHS members from better socio-
economic backgrounds. These findings are compatible
with national studies [13]. We can conclude that it is
relatively easy to encourage patients from poor socio-
economic backgrounds to perform these tests because
they require fewer personal resources than do the
achievement of good health outcomes. Research into
barriers to favorable outcomes is required in order to
develop more appropriate disparity-reducing strategies.
Ethnicity
Results from the analysis of diabetes prevalence, follow-
up examinations and HbA1C control demonstrated con-
siderable disparities between Israel’s Arab and non Arab
population. These findings further confirm the findings
from our previous study, which demonstrated disparities
in mammography utilization among MHS Arab mem-
bers and which suggested that language and socio-cul-
tural barriers contributed to these gaps [26]. Other
national-level reports present similar findings [27].
The literature provides significant evidence of the
health disparities suffered by ethnic minorities [24]. One
interesting finding published recently is that not all of
the disparities described can be related to individual
characteristics. Evidence of racial differences in diabetes
outcomes that were related to physician practice has
been found. One study showed that individual physi-
cians achieved less favorable outcomes among their
black than among their white patients [28]. These find-
ings challenge society and health organizations to iden-
tify solutions for “unequal treatment” [29]. MHS has
begun implementing interventions tailor-made for the
Arab population [26]; see below for its organization-
wide action plan.
Supplementary Voluntary Health Insurance (SVHI)
As mentioned, MHS offers its members the opportunity
to purchase SVHI for services not included in the basic
package, such as certain types of medical devices or
greater choice among the services included in the pack-
age. 87% of MHS members overall, and the same per-
centage among diabetic patients, have purchased SVHI.
Our findings suggest that MHS members who pur-
chased SVHI are more likely to perform optimal follow
up and achieve appropriate disease control. Follow-up
examinations, for example, are relatively simple to per-
form and free of charge - irrespective of SVHI ownership.
Therefore, it appears that financial barriers to purchasing
SVHI or paying the relatively small co-payment when
using the relevant services are probably not the causal
agent for less favorable health outcomes between groups;
instead, it appears that the lack of SVHI is an important
indicator for a variety of population characteristics that
are associated with poor health habits and other yet uni-
dentified intervening variables that might contribute to
poorer health outcomes. These findings support our pre-
vious suggestion regarding the influence of individual
resources rather than financial resources on health.
Immigration
In the 1990s, Israel became home to a huge wave of
immigration, primarily from Former Soviet Union coun-
tries. This group is characterized by its high educational
level, relatively good assimilation into Israeli society and
relatively long residence in Israel (10 years and more) at
the time of the study. These factors, in addition to other
special characteristics of these group, may explain our
findings. Cultural and language barriers might also be
less significant since many of the GPs and nurses treat-
ing MHS patients are themselves former immigrants
from the same countries.
From analysis to an action plan
The results of this study helped our organization to iden-
tify members from a poor socioeconomic background
and those who are from diverse ethnicity as populations
at risk for health disparities. These findings were pre-
sented to MHS central management by it’s division of
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ability of local improvement-oriented initiatives to pro-
mote care while decreasing disparities [26].
As a result, in 2009 MHS decided to adopt equity, or
the reduction in disparities, as a strategic organizational
mission. This was translated to an action plan applied in
the following major domains: (1) Preferential allocation
of resources - a dedicated or “marked” budget - to regio-
nal and branch organizational units that serve weak
populations; (2) Adaptation of MHS services to the spe-
cial needs of culturally diverse populations, including
recruitment of caregivers and managers from minority
communities to better represent these population groups.
It requires long-term perseverance and dedication to
reduce disparities. This means going beyond the initial
efforts made by MHS and some other Israeli health
plans. There is great need for a joint nationwide effort
involving various stakeholders - governmental and non-
governmental, HMOs, other social and health organiza-
tions and patient representatives- to close the existing
gap in health outcomes.
Limitations
Eligibility
Our subjects were eligible for participation in the study
if they had visited their GP at least once during the pre-
vious two years. This criterion was set because we
wanted our study population to be as homogeneous as
possible in service utilization and patient-physician rela-
tionship. Six percent of our members were thus
excluded from our analysis because they were ineligible.
A preliminary analysis of diabetic patients who have not
visited their GP in the previous two years indicated that
this is a population at great risk for poor health out-
comes and should therefore be analyzed separately. We
do not consider this fact as a selection bias.
Ethnicity
Ethnic identity is not available to HMOs for historical
reasons, mainly to avoid discrimination. Hence, we iden-
tified Arab members by location of residence. We esti-
mate that 90% of this group was identified and
participated in our study. We now know that informa-
tion on ethnicity and other socio-cultural characteristics
is crucial to ensure equitable health outcomes. New
methods are needed to precisely identify Arab members
and to provide them with culturally appropriate, tailor-
made services.
Immigration
In this study we gathered data on immigrants who had
arrived to Israel from the FSU. This group comprises
the vast majority of recent immigrants living in our
country and insured by MHS. Efforts should be made to
reach other, samller immigrant groups (e.g., Ethiopians).
SER
We classified our members according to the SERs
assigned to their locality by the Israel Central Bureau of
Statistics (CBS) because MHS does not collect individual
data on socio-economic status, such as educational level
and income. This information is available at the CBS
and social security authorities but not transferred to the
health plans for regulatory reasons. Although we
assumed that districts with populations of at least 3,000
would be homogeneous, direct individual data would be
preferable.
Indirect Evaluation of Outcomes
We were able to analyze only intermediate outcome
measures known to be associated with diabetic compli-
cations. Our databases are not designed to directly ana-
lyze diabetes-related mortality and other diabetes
complications, mainly due to the inadequate data flow-
ing from hospitals to the health plans.
Conclusion
Low socio-economic status and belonging to an ethnic
minority are associated with less favorable diabetes care
and control. Immigration from FSU countries was not a
factor influencing diabetes care and outcomes. Lack of
supplementary health insurance emerged as an indicator
for a range of population characteristics associated with
poor health outcomes. The action plan that MHS has
formulated is aimed at allocating managerial, staff and
financial resources to populations at risk. We hope that
these actions will result in a substantial reduction in dis-
parities over the coming years.
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